Danny Ramzy1, Vivek Rao, Julie Brahm
1Heart Transplant Program, Toronto General Hospital, University Health Network, Division of Cardiac Surgery, University of Toronto, Toronto, ON.
Cardiac allograft vasculopathy (CAV) is a serious complication after heart transplants. Preventing CAV by managing risk factors is crucial due to limited treatment options and poor outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: